Journal of Oncology and Cancer Research

Shirin Shojaei is a biomedical researcher and upcoming Ph.D. candidate in Mechanical Engineering at McGill University. Her interdisciplinary work bridges nanomedicine, biomaterials, and drug delivery systems for cancer therapy. She has contributed to multiple peer-reviewed publications, serves as a reviewer for top journals, and actively participates in global research collaborations. Her scientific vision focuses on integrating engineering principles with biomedical innovation to enhance translational cancer treatments.

• Immunotherapy, Targeted Therapy
• Hyperthermia Therapy

1. Reviewer for high-impact journals including:
2. Naunyn-Schmiedeberg's Archives of Pharmacology
3. Discover Oncology
4. Cell Biology and Toxicology
5. Journal of Nanobiotechnology
6. Speaker in webinars (2025) on:
7. Targeted Drug Delivery in Cancer Treatment
8. The Role of Nanoparticles in Targeted Drug Delivery
9. Collaborates with international research teams in translational cancer research
10. Patent Holder:
11. Automated Safe Radiopharmaceutical System (Patent No: 95768, 2018)
12. Automatic Radiopharmaceutical Preparation System with Remote Control Capability (Submitted)

1. Development of 5-fluorouracil/etoposide co-loaded electrospun nanofibrous scaffold for localized anti-melanoma therapy. Journal of Applied Biomaterials & Functional Materials.
2. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies. Journal of Drug Delivery Science and Technology.
3. Production of a magnetic nanocomposite for biological and hyperthermia applications. International Journal of Biological Macromolecules.
4. Design and fabrication of a magnetic nanobiocomposite based on flaxseed mucilage hydrogel and silk fibroin for biomedical applications. Scientific Reports.
5. Nanomaterials loaded with Quercetin as an advanced tool for cancer treatment. Journal of Drug Delivery Science and Technology.